Cargando…

Protective Effect of Glucosinolates Hydrolytic Products in Neurodegenerative Diseases (NDDs)

Crucifer vegetables, Brassicaceae and other species of the order Brassicales, e.g., Moringaceae that are commonly consumed as spice and food, have been reported to have potential benefits for the treatment and prevention of several health disorders. Though epidemiologically inconclusive, investigati...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaafaru, Mohammed Sani, Abd Karim, Nurul Ashikin, Enas, Mohamad Eliaser, Rollin, Patrick, Mazzon, Emanuela, Abdull Razis, Ahmad Faizal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986460/
https://www.ncbi.nlm.nih.gov/pubmed/29738500
http://dx.doi.org/10.3390/nu10050580
_version_ 1783328928452050944
author Jaafaru, Mohammed Sani
Abd Karim, Nurul Ashikin
Enas, Mohamad Eliaser
Rollin, Patrick
Mazzon, Emanuela
Abdull Razis, Ahmad Faizal
author_facet Jaafaru, Mohammed Sani
Abd Karim, Nurul Ashikin
Enas, Mohamad Eliaser
Rollin, Patrick
Mazzon, Emanuela
Abdull Razis, Ahmad Faizal
author_sort Jaafaru, Mohammed Sani
collection PubMed
description Crucifer vegetables, Brassicaceae and other species of the order Brassicales, e.g., Moringaceae that are commonly consumed as spice and food, have been reported to have potential benefits for the treatment and prevention of several health disorders. Though epidemiologically inconclusive, investigations have shown that consumption of those vegetables may result in reducing and preventing the risks associated with neurodegenerative disease development and may also exert other biological protections in humans. The neuroprotective effects of these vegetables have been ascribed to their secondary metabolites, glucosinolates (GLs), and their related hydrolytic products, isothiocyanates (ITCs) that are largely investigated for their various medicinal effects. Extensive pre-clinical studies have revealed more than a few molecular mechanisms of action elucidating multiple biological effects of GLs hydrolytic products. This review summarizes the most significant and up-to-date in vitro and in vivo neuroprotective actions of sulforaphane (SFN), moringin (MG), phenethyl isothiocyanate (PEITC), 6-(methylsulfinyl) hexyl isothiocyanate (6-MSITC) and erucin (ER) in neurodegenerative diseases.
format Online
Article
Text
id pubmed-5986460
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-59864602018-06-05 Protective Effect of Glucosinolates Hydrolytic Products in Neurodegenerative Diseases (NDDs) Jaafaru, Mohammed Sani Abd Karim, Nurul Ashikin Enas, Mohamad Eliaser Rollin, Patrick Mazzon, Emanuela Abdull Razis, Ahmad Faizal Nutrients Review Crucifer vegetables, Brassicaceae and other species of the order Brassicales, e.g., Moringaceae that are commonly consumed as spice and food, have been reported to have potential benefits for the treatment and prevention of several health disorders. Though epidemiologically inconclusive, investigations have shown that consumption of those vegetables may result in reducing and preventing the risks associated with neurodegenerative disease development and may also exert other biological protections in humans. The neuroprotective effects of these vegetables have been ascribed to their secondary metabolites, glucosinolates (GLs), and their related hydrolytic products, isothiocyanates (ITCs) that are largely investigated for their various medicinal effects. Extensive pre-clinical studies have revealed more than a few molecular mechanisms of action elucidating multiple biological effects of GLs hydrolytic products. This review summarizes the most significant and up-to-date in vitro and in vivo neuroprotective actions of sulforaphane (SFN), moringin (MG), phenethyl isothiocyanate (PEITC), 6-(methylsulfinyl) hexyl isothiocyanate (6-MSITC) and erucin (ER) in neurodegenerative diseases. MDPI 2018-05-08 /pmc/articles/PMC5986460/ /pubmed/29738500 http://dx.doi.org/10.3390/nu10050580 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Jaafaru, Mohammed Sani
Abd Karim, Nurul Ashikin
Enas, Mohamad Eliaser
Rollin, Patrick
Mazzon, Emanuela
Abdull Razis, Ahmad Faizal
Protective Effect of Glucosinolates Hydrolytic Products in Neurodegenerative Diseases (NDDs)
title Protective Effect of Glucosinolates Hydrolytic Products in Neurodegenerative Diseases (NDDs)
title_full Protective Effect of Glucosinolates Hydrolytic Products in Neurodegenerative Diseases (NDDs)
title_fullStr Protective Effect of Glucosinolates Hydrolytic Products in Neurodegenerative Diseases (NDDs)
title_full_unstemmed Protective Effect of Glucosinolates Hydrolytic Products in Neurodegenerative Diseases (NDDs)
title_short Protective Effect of Glucosinolates Hydrolytic Products in Neurodegenerative Diseases (NDDs)
title_sort protective effect of glucosinolates hydrolytic products in neurodegenerative diseases (ndds)
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986460/
https://www.ncbi.nlm.nih.gov/pubmed/29738500
http://dx.doi.org/10.3390/nu10050580
work_keys_str_mv AT jaafarumohammedsani protectiveeffectofglucosinolateshydrolyticproductsinneurodegenerativediseasesndds
AT abdkarimnurulashikin protectiveeffectofglucosinolateshydrolyticproductsinneurodegenerativediseasesndds
AT enasmohamadeliaser protectiveeffectofglucosinolateshydrolyticproductsinneurodegenerativediseasesndds
AT rollinpatrick protectiveeffectofglucosinolateshydrolyticproductsinneurodegenerativediseasesndds
AT mazzonemanuela protectiveeffectofglucosinolateshydrolyticproductsinneurodegenerativediseasesndds
AT abdullrazisahmadfaizal protectiveeffectofglucosinolateshydrolyticproductsinneurodegenerativediseasesndds